You are here

  • Home
  • Archive
  • Volume 20, Issue 2
  • Similar clinical outcomes but more healthcare use in shoulder impingement patients following corticosteroid injection compared with physical therapy

Article Text

Article menu
Download PDFPDF
Therapeutics/Prevention
Randomised controlled trial
Similar clinical outcomes but more healthcare use in shoulder impingement patients following corticosteroid injection compared with physical therapy
  1. Nadine E Foster
  1. Keele University, Research Institute of Primary Care and Health Sciences, Keele, Staffordshire, UK
  1. Correspondence to : Professor Nadine E Foster, Keele University, Research Institute of Primary Care and Health Sciences, David Weatherall Building, Keele, Staffordshire ST5 5BG, UK; n.foster{at}keele.ac.uk

https://doi.org/10.1136/ebmed-2015-110171

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Commentary on: Rhon DI, Boyles RB, Cleland JA. One-year outcome of subacromial corticosteroid injection compared with manual physical therapy for the management of unilateral shoulder impingement syndrome. Ann Intern Med 2014;161:161–9.OpenUrlCrossRefPubMedWeb of Science

    Context

    Subacromial shoulder impingement syndrome (SIS) can cause shoulder problems and corticosteroid injections and physical therapy (exercise and manual therapy) are among the most common treatments. This randomised controlled trial (RCT) compares these treatments in adults with SIS.

    Methods

    This RCT recruited 104 patients with SIS who had been referred to physical therapy and who had at least a score of 20 (of 100) on the Shoulder Pain and Disability Index (SPADI).1 Patients were randomised to a package of physical therapy (delivered two times per week over 3 weeks) and a home exercise programme or to a package of subacromial corticosteroid injection (40 mg of triamcinolone acetonide in up to three injections over 12 months) and written …

    View Full Text

    Footnotes

    • Competing interests None.

    • Provenance and peer review Commissioned; internally peer reviewed.